Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme (vol 476, pg 409, 2020)

被引:1
|
作者
Ohashi, Riuko [1 ,2 ,3 ]
Martignoni, Guido [4 ,5 ]
Hartmann, Arndt [6 ]
Calio, Anna [4 ]
Segala, Diego [5 ]
Stoehr, Christine [6 ]
Wach, Sven [7 ]
Erlmeier, Franziska [6 ,8 ]
Weichert, Wilko [8 ]
Autenrieth, Michael [9 ]
Schraml, Peter [2 ]
Rupp, Niels J. [2 ]
Ohe, Chisato [10 ]
Otsuki, Yoshiro [11 ]
Kawasaki, Takashi [12 ]
Kobayashi, Hiroshi [13 ]
Kobayashi, Kazuhiro [14 ]
Miyazaki, Tatsuhiko [14 ]
Shibuya, Hiroyuki [15 ]
Usuda, Hiroyuki [16 ]
Umezu, Hajime [17 ]
Fujishima, Fumiyoshi [18 ]
Furusato, Bungo [19 ,20 ]
Osakabe, Mitsumasa [21 ]
Sugai, Tamotsu [21 ]
Kuroda, Naoto [22 ]
Tsuzuki, Toyonori [23 ]
Nagashima, Yoji [24 ]
Ajioka, Yoichi [1 ,3 ]
Moch, Holger [2 ]
机构
[1] Niigata Univ, Histopathol Core Facil, Fac Med, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan
[2] Univ & Univ Hosp Zurich, Dept Pathol & Mol Pathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland
[3] Niigata Univ, Div Mol & Diagnost Pathol, Grad Sch Med & Dent Sci, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan
[4] Univ Verona, Dept Diagnost & Publ Hlth, Piazzale Ludovico Antonio Scuro 10, I-37134 Verona, Italy
[5] Pederzoli Hosp, Dept Pathol, Via Monte Baldo 24, I-37019 Peschiera Del Garda, Italy
[6] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Pathol, Krankenhausstr 8-10, D-91054 Erlangen, Germany
[7] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Urol & Pediat Urol, Krankenhausstr 12, D-91054 Erlangen, Germany
[8] Tech Univ Munich, Inst Pathol, Trogerstr 18, D-81675 Munich, Germany
[9] Tech Univ Munich, Dept Urol, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany
[10] Kansai Med Univ, Dept Pathol & Lab Med, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan
[11] Seirei Hamamatsu Gen Hosp, Dept Pathol, Naka Ku, 2-12-12 Sumiyoshi, Hamamatsu, Shizuoka 4308558, Japan
[12] Niigata Canc Ctr Hosp, Dept Pathol, Chuo Ku, 2-15-3 Kawagishi Cho, Niigata 9518566, Japan
[13] Tachikawa Gen Hosp, Dept Pathol, 1-24 Asahioka, Nagaoka, Niigata 9408621, Japan
[14] Gifu Univ Hosp, Dept Pathol, 1-1 Yanagido, Gifu 5011194, Japan
[15] Niigata City Gen Hosp, Dept Pathol, Chuo Ku, 463-7 Shumoku, Niigata 9501197, Japan
[16] Nagaoka Red Cross Hosp, Dept Diagnost Pathol, 2-297-1 Sensyu, Nagaoka, Niigata 9402085, Japan
[17] Niigata Univ, Div Pathol, Med & Dent Hosp, Chuo Ku, 1-754 Asahimachi Dori, Niigata 9518520, Japan
[18] Tohoku Univ, Dept Anat Pathol, Grad Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan
[19] Nagasaki Univ Hosp, Canc Genom Unit, Clin Genom Ctr, 1-7-1 Sakamoto, Nagasaki 8528501, Japan
[20] Nagasaki Univ, Dept Pathol, Grad Sch Biomed Sci, 1-7-1 Sakamoto, Nagasaki 8528501, Japan
[21] Iwate Med Univ, Sch Med, Dept Mol Diagnost Pathol, 2-1-1 Idai Dori, Yahaba, Iwate 0283695, Japan
[22] Kochi Red Cross Hosp, Dept Diagnost Pathol, 1-4-63-11 Hadaminamimachi, Kochi 7808562, Japan
[23] Aichi Med Univ Hosp, Dept Surg Pathol, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan
[24] Tokyo Womens Med Univ Hosp, Dept Surg Pathol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan
基金
瑞士国家科学基金会;
关键词
Chromophobe renal cell carcinoma; Kidney; Mitosis; Necrosis; Prognosis; Sarcomatoid differentiation; The Cancer Genome Atlas (TCGA); Tumor grade;
D O I
10.1007/s00428-020-02786-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The legends of Figs. 1 and 3 in the published original version of the above article are incorrect.
引用
收藏
页码:419 / 422
页数:4
相关论文
共 7 条
  • [1] Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme
    Riuko Ohashi
    Guido Martignoni
    Arndt Hartmann
    Anna Caliò
    Diego Segala
    Christine Stöhr
    Sven Wach
    Franziska Erlmeier
    Wilko Weichert
    Michael Autenrieth
    Peter Schraml
    Niels J. Rupp
    Chisato Ohe
    Yoshiro Otsuki
    Takashi Kawasaki
    Hiroshi Kobayashi
    Kazuhiro Kobayashi
    Tatsuhiko Miyazaki
    Hiroyuki Shibuya
    Hiroyuki Usuda
    Hajime Umezu
    Fumiyoshi Fujishima
    Bungo Furusato
    Mitsumasa Osakabe
    Tamotsu Sugai
    Naoto Kuroda
    Toyonori Tsuzuki
    Yoji Nagashima
    Yoichi Ajioka
    Holger Moch
    Virchows Archiv, 2020, 476 : 409 - 418
  • [2] Re: Multi-institutional Re-evaluation of Prognostic Factors in Chromophobe Renal Cell Carcinoma: Proposal of a Novel Two-tiered Grading Scheme
    Cimadamore, Alessia
    Cheng, Liang
    Ohashi, Riuko
    Scarpelli, Marina
    Lopez-Beltran, Antonio
    Moch, Holger
    Montironi, Rodolfo
    EUROPEAN UROLOGY, 2020, 78 (01) : 114 - 116
  • [3] Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme
    Riuko Ohashi
    Guido Martignoni
    Arndt Hartmann
    Anna Caliò
    Diego Segala
    Christine Stöhr
    Sven Wach
    Franziska Erlmeier
    Wilko Weichert
    Michael Autenrieth
    Peter Schraml
    Niels J. Rupp
    Chisato Ohe
    Yoshiro Otsuki
    Takashi Kawasaki
    Hiroshi Kobayashi
    Kazuhiro Kobayashi
    Tatsuhiko Miyazaki
    Hiroyuki Shibuya
    Hiroyuki Usuda
    Hajime Umezu
    Fumiyoshi Fujishima
    Bungo Furusato
    Mitsumasa Osakabe
    Tamotsu Sugai
    Naoto Kuroda
    Toyonori Tsuzuki
    Yoji Nagashima
    Yoichi Ajioka
    Holger Moch
    Virchows Archiv, 2020, 476 : 419 - 422
  • [4] Prognostic impact of rhabdoid differentiation incorporated in a novel two-tiered grading system for chromophobe renal cell carcinoma
    Ohashi, R.
    Takamura, K.
    Ohe, C.
    Kobayashi, H.
    Schraml, P.
    Rupp, N.
    Kuroda, N.
    Tsuzuki, T.
    Ajioka, Y.
    Moch, H.
    VIRCHOWS ARCHIV, 2020, 477 : S165 - S165
  • [5] Prognostic Significance of Neuroendocrine Differentiation and a Two-Tiered Grading System in Chromophobe Renal Cell Carcinoma: A Study of 128 Tumors
    Bai, Shi
    Wu, Shulin
    Devins, Kyle
    Sadow, Peter
    Oliva, Esther
    Wu, Chin-Lee
    Cornejo, Kristine
    LABORATORY INVESTIGATION, 2024, 104 (03) : S905 - S906
  • [6] Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis (vol 15, pg 495, 2020)
    Iacovelli, Roberto
    Ciccarese, Chiara
    Facchini, Gaetano
    Milella, Michele
    Urbano, Federica
    Basso, Umberto
    De Giorgi, Ugo
    Sabbatini, Roberto
    Santini, Daniele
    Berardi, Rossana
    Santoni, Matteo
    Bracarda, Sergio
    Massari, Francesco
    Masini, Cristina
    De Tursi, Michele
    Ricotta, Riccardo
    Buti, Sebastiano
    Zustovich, Fable
    Sepe, Pierangela
    Rossetti, Sabrina
    Maruzzo, Marco
    Cortesi, Enrico
    Tortora, Giampaolo
    Procopio, Giuseppe
    TARGETED ONCOLOGY, 2020, 15 (05) : 691 - 691
  • [7] Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) (vol 3, pg 256, 2021)
    Marchioni, Michele
    Kriegmair, Maximilian
    Heck, Mathias
    Amiel, Thomas
    Porpiglia, Francesco
    Checcucci, Enrico
    Campi, Riccardo
    Minervini, Andrea
    Mari, Andrea
    Van Bruwaene, Siska
    Linares, Estefania
    Hevia, Vital
    Musquera, Mireia
    D'Anna, Mauricio
    Derweesh, Ithaar
    Bradshaw, Aaron
    Autorino, Riccardo
    Guruli, Georgi
    Veccia, Alessandro
    Roussel, Eduard
    Albersen, Maarten
    Pavan, Nicola
    Claps, Francesco
    Antonelli, Alessandro
    Palumbo, Carlotta
    Klatte, Tobias
    Erdem, Selcuk
    Mir, Maria Carmen
    EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (03): : 517 - 517